Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatmentDenise Obrecht, Stefan Rutkowski, Rudolf Schwarz et al.|Neuro-Oncology|2024Cited by 1
MEDB-16. Persistent radiological lesions at the end of primary therapy in childhood medulloblastoma: residual lesion or active residual tumor?Lena Schömig, Martin Benesch, Denise Obrecht et al.|Neuro-Oncology|2022Cited by 0